JP Morgan Chase
YDES icon

JP Morgan Chase’s YD Bio Ltd YDES Stock Holding History

JP Morgan Chase’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38 Buy
+5
New +$16 ﹤0.01% 7922

Other funds holding YDES

Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Garrett Wealth Advisory Group
Garrett Wealth Advisory Group Weatherford, Texas $659M AUM 19.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Cypress Capital Management (Wyoming)
Cypress Capital Management (Wyoming) Sheridan, Wyoming $126M AUM 27.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase's YDES Position: Q3 2026 in Review

JP Morgan Chase opened a new position in YD Bio Ltd (YDES) in Q3 2026: 5 shares worth $38. The stake represents ﹤0.01% of the portfolio and ranks #7922 among its holdings.

9 funds tracked by Wall St. Rank hold YDES as of Q3 2026.

  • JP Morgan Chase held 5 shares of YD Bio Ltd worth $38 as of Q3 2026.
  • YD Bio Ltd was a new JP Morgan Chase position in Q3 2026.
  • YD Bio Ltd made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7922 holding.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.